Skip to main content
logo
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
26.98
-0.57 (-2.07%)
At close: May 18, 2026, 4:00 PM EDT
27.00
+0.02 (0.07%)
Pre-market: May 19, 2026, 4:42 AM EDT

Legend Biotech Revenue

Legend Biotech had revenue of $305.10M in the quarter ending March 31, 2026, with 56.46% growth. This brings the company's revenue in the last twelve months to $1.14B, up 56.38% year-over-year. In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth.

Revenue (ttm)
$1.14B
Revenue Growth
+56.38%
P/S Ratio
4.40
Revenue / Employee
$384,148
Employees
2,965
Market Cap
5.01B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.03B401.60M64.02%
Dec 31, 2024627.30M342.20M120.03%
Dec 31, 2023285.10M168.10M143.66%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 202075.00M15.02M25.04%
Dec 31, 201959.98M10.85M22.08%
Dec 31, 201849.13M25.54M108.24%
Dec 31, 201723.59M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
PTC Therapeutics827.11M
TG Therapeutics700.35M
Mirum Pharmaceuticals569.61M
Xenon Pharmaceuticals7.50M
CG Oncology5.07M
CRISPR Therapeutics AG4.10M
Dianthus Therapeutics1.34M
Revenue Rankings

LEGN News

More News